BioSample Inc.

In the course of validating disease targets or developing drugs, researchers need tissue samples from patients with specific types of diseases as well as from healthy patients.BioSample Inc., has an internet-enabled biological material procurement solution to the pharmaceutical/biotech community.

Two years ago, Martin Cusack, a businessman who had founded several start-ups in a variety of industries, chanced to be standing near the fax machine in a small medical clinic in South Florida. Faxes from researchers at well-known institutions like Johns Hopkins and the Mayo Clinic, as well as from multinational pharmaceutical companies, came in continually, says Cusack, although there wasn't that much activity in the clinic.

In the course of validating disease targets or developing drugs, researchers need tissue samples from patients with specific types of...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

More from Business

UCB Follows Fellow European Pharmas With Major US Investment

 
• By 

The Belgian drugmaker is boosting its biologics capacity over the pond.

AstraZeneca Taps Into China’s R&D Engine With CSPC Alliance

 

After in-licensing a cardiovascular candidate last year, AstraZeneca has signed a strategic drug discovery alliance, which could generate billions of dollars in payments to the Chinese firm.

Finance Watch: Insmed Cashes In On Positive Data With $750m Offering

 
• By 

Public Company Edition: Insmed raised $750m after reporting positive Phase IIb data in PAH, Cogent accessed up to $400m in new debt, Kelun-Biotech netted $250m in a placement of shares and ADC revealed a $100m private placement. In strategic updates, Recursion cut 20% of its jobs.